These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 24880585)

  • 1. Experimental and Monte Carlo dosimetric characterization of a 1 cm (103)Pd brachytherapy source.
    Reed JL; Rivard MJ; Micka JA; Culberson WS; DeWerd LA
    Brachytherapy; 2014; 13(6):657-67. PubMed ID: 24880585
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Monte Carlo calculations and experimental measurements of the TG-43U1-recommended dosimetric parameters of 125I (Model IR-Seed2) brachytherapy source.
    Sheikholeslami S; Nedaie HA; Sadeghi M; Pourbeigy H; Shahzadi S; Zehtabian M; Hasani M; Meigooni AS
    J Appl Clin Med Phys; 2016 Jul; 17(4):430-441. PubMed ID: 27455485
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 103Pd strings: Monte Carlo assessment of a new approach to brachytherapy source design.
    Rivard MJ; Reed JL; DeWerd LA
    Med Phys; 2014 Jan; 41(1):011716. PubMed ID: 24387508
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Experimental determination of the Task Group-43 dosimetric parameters of the new I25.S17plus (125)I brachytherapy source.
    Moutsatsos A; Pantelis E; Papagiannis P; Baltas D
    Brachytherapy; 2014; 13(6):618-26. PubMed ID: 25108795
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dosimetric characteristics of the InterSource103 palladium brachytherapy source.
    Meigooni AS; Sowards K; Soldano M
    Med Phys; 2000 May; 27(5):1093-100. PubMed ID: 10841414
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Experimental and Monte Carlo determination of the TG-43 dosimetric parameters for the model 9011 THINSeed brachytherapy source.
    Kennedy RM; Davis SD; Micka JA; DeWerd LA
    Med Phys; 2010 Apr; 37(4):1681-8. PubMed ID: 20443489
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Experimental measurements and Monte Carlo calculations of dosimetric parameters of the IRA1-103Pd brachytherapy source.
    Sadeghi M; Hosseini SH; Raisali G
    Appl Radiat Isot; 2008 Oct; 66(10):1431-7. PubMed ID: 18387806
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Air-kerma strength determination of a new directional (103)Pd source.
    Aima M; Reed JL; DeWerd LA; Culberson WS
    Med Phys; 2015 Dec; 42(12):7144-52. PubMed ID: 26632069
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thermoluminescent and Monte Carlo dosimetry of IR06-103Pd brachytherapy source.
    Saidi P; Sadeghi M; Hosseini SH; Tenreiro C
    J Appl Clin Med Phys; 2011 Nov; 12(4):3581. PubMed ID: 22089014
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dosimetric characteristics of the bests double-wall 103Pd brachytherapy source.
    Meigooni AS; Bharucha Z; Yoe-Sein M; Sowards K
    Med Phys; 2001 Dec; 28(12):2568-75. PubMed ID: 11797962
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Monte Carlo-aided dosimetry of the theragenics TheraSeed model 200 103Pd interstitial brachytherapy seed.
    Monroe JI; Williamson JF
    Med Phys; 2002 Apr; 29(4):609-21. PubMed ID: 11991133
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thermoluminescent and Monte Carlo dosimetry of a new 170Tm brachytherapy source.
    Nazari S; Sadeghi M; Shirvani-Arani S; Bahrami-Samani A; Saidi P
    Phys Med; 2014 Mar; 30(2):178-83. PubMed ID: 23764298
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A modern Monte Carlo investigation of the TG-43 dosimetry parameters for an 125I seed already having AAPM consensus data.
    Aryal P; Molloy JA; Rivard MJ
    Med Phys; 2014 Feb; 41(2):021702. PubMed ID: 24506593
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dosimetric characterization of the M-15 high-dose-rate Iridium-192 brachytherapy source using the AAPM and ESTRO formalism.
    Ho Than MT; Munro Iii JJ; Medich DC
    J Appl Clin Med Phys; 2015 May; 16(3):5270. PubMed ID: 26103489
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of improved TLD dosimetry on the determination of dose rate constants for (125)I and (103)Pd brachytherapy seeds.
    Rodriguez M; Rogers DW
    Med Phys; 2014 Nov; 41(11):114301. PubMed ID: 25370677
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Monte Carlo calculation of dosimetry parameters for the IR08-103Pd brachytherapy source.
    Saidi P; Sadeghi M; Shirazi A; Tenreiro C
    Med Phys; 2010 Jun; 37(6):2509-15. PubMed ID: 20632562
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Experimental determination of dosimetric characterization of a newly designed encapsulated interstitial brachytherapy source of 103Pd-model Pd-1.
    Nath R; Yue N; Roa E
    Med Phys; 2002 Oct; 29(10):2433-4. PubMed ID: 12408318
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dosimetric parameters of the new design (103)Pd brachytherapy source based on Monte Carlo study.
    Saidi P; Sadeghi M; Shirazi A; Tenreiro C
    Phys Med; 2012 Jan; 28(1):13-8. PubMed ID: 21251862
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dosimetric characteristics of the Pharma Seed model BT-125-I source.
    Popescu CC; Wise J; Sowards K; Meigooni AS; Ibbott GS
    Med Phys; 2000 Sep; 27(9):2174-81. PubMed ID: 11011748
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Theoretical and experimental determination of dosimetric characteristics for brachyseed Pd-103, model Pd-1, source.
    Meigooni AS; Zhang H; Perry C; Dini SA; Koona RA
    Appl Radiat Isot; 2003 May; 58(5):533-41. PubMed ID: 12735969
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.